Rebound inflammation and the risk of ischemic stroke after discontinuation of aspirin therapy.
Pijak
Michal R
MR
D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects*; D002545:Brain Ischemia / Q000139:chemically induced*; D002097:C-Reactive Protein / Q000032:analysis; D006801:Humans; D007249:Inflammation; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D020521:Stroke / Q000139:chemically induced*
D010975:Platelet Aggregation Inhibitors; D002097:C-Reactive Protein; D001241:Aspirin